These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17828634)

  • 1. The pharmacological management of behavioural disturbance in psychosis: a naturalistic study.
    Daniel J; Chamberlain J; Castle D
    Australas Psychiatry; 2007 Oct; 15(5):380-4. PubMed ID: 17828634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the initial treatment phase in first-episode psychosis.
    Power P; Elkins K; Adlard S; Curry C; McGorry P; Harrigan S
    Br J Psychiatry Suppl; 1998; 172(33):71-6. PubMed ID: 9764130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
    Aparasu RR; Jano E; Johnson ML; Chen H
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).
    Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE;
    Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [25 years antipsychotics: back to the future?].
    Denys D; de Haan L
    Tijdschr Psychiatr; 2008; 50 Spec no.():105-9. PubMed ID: 19067308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic use in the elderly: what doctors say they do, and what they do.
    Tiller J; Ames D; Brodaty H; Byrne G; Chawla S; Halliday G; Snowdon J; Hepworth G; McArdle P; Schweitzer I
    Australas J Ageing; 2008 Sep; 27(3):134-42. PubMed ID: 18713173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics in the treatment of children and adolescents.
    Findling RL
    J Clin Psychiatry; 2004; 65 Suppl 6():3-4. PubMed ID: 15104520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological treatment of psychotic conditions].
    Fink-Jensen A; Larsen JT; Nielsen B; Lublin H
    Ugeskr Laeger; 2008 Nov; 170(46):3750-3. PubMed ID: 19014721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
    Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
    Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2008 Apr; 44(2):120-3. PubMed ID: 18366366
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine-induced agranulocytosis in an adolescent male with psychosis.
    Freedman JL; Ryan CA; Coffey BJ
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):185-9. PubMed ID: 21504357
    [No Abstract]   [Full Text] [Related]  

  • 19. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.